4-Chloro-2,5-dimethoxyamphetamine

From Wikipedia, the free encyclopedia


DOC
Chemical name 4-chloro-2,5-Dimethoxy-amphetamine or
1-(4-chloro-2,5-dimethoxyphenyl)-2-aminopropane
Chemical formula C11H16NO2
Molar mass 229.70628 \begin{matrix} \frac{g}{mol} \end{matrix}
266.16692 \begin{matrix} \frac{g}{mol} \end{matrix} (hydrochloride salt)
Melting point 187-188 °C and 193-194.5 (hydrochloride)
CAS numbers  ?
SMILES COc1cc(C[C@@H](C)N)c(cc1Cl)OC
Chemical structure of DOC

4-Chloro-2,5-dimethoxyamphetamine or 4-Chloro-2,5-DMA or DOC is a psychedelic hallucinogenic drug of the phenethylamine family. Used by some as an entheogen, DOC was presumably first synthesized by Alexander Shulgin. The drug is generally taken orally, but some users have been known to insufflate or smoke the pure powder.

Contents

DOC is a substituted alpha-methylated phenethylamine, a class of compounds commonly known as amphetamines. The full name of the chemical is 2,5-dimethoxy-4-chloro-amphetamine. DOC has a stereocenter and R-(-)-DOC is the more active stereoisomer. DOC is the 3-carbon chain homologue of the psychedelic 2C-C.

A normal average dose of DOC ranges from 1.5-3.0 mg; the former producing threshold effects, and the latter producing strong effects. Doses up to 10mg have been known to send the user into a restless stupor. Onset of the drug is 1-3 hours, peak and plateau at 4-8 hours, and a gradual come down. After effects can last well into the next day.

Unlike simple amphetamines, DOC is a psychedelic that resemble LSD, DOB, and amphetamines. These effects include open and closed eye visuals, increased appreciation of music, increased awareness of sound and movement, euphoria, and a feeling of god within.

The mechanism of DOC’s hallucinogenic effects is unknown, but like DOB and DOI, it may be mediated by partial agonistic activity at the 5-HT2A serotonin receptor, and binding affinity for the 5-HT2B and the 5-HT2C serotonin receptor.

The toxicity of DOC is not known, but nausea, chest pains, and vasoconstriction have been reported by some users. In June 2006 four teenagers were admitted to a hospital in Metropolitan Detroit, Michigan after accidentally overdosing DOC.[1] To date, there have been no deaths attributed to DOC. However, DOC is an extremely potent psychoactive, and the risk of overdose is great if unknown or extreme dosages are taken.

Although rare on the black market, sales of DOC on blotter paper and in capsules was reported in late 2005. DOC is sometimes misrepresented as LSD by unscrupulous dealers. This is particularly dangerous, as DOC is not known to have the safety profile of LSD.

4-chloro-2,5-dimethoxyamphetamine is unscheduled in the United States. It is likely that it would be considered an analogue (of DOB or DOM), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. In the United States, the analogues 2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxyamphetamine, and 4-methyl-2,5-dimethoxyamphetamine are Schedule I controlled substances. DOC is scheduled in many other countries including Canada, Germany, New Zealand, Sweden and the UK.

Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.